Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
The DOI matches its Crossref record; 24 of the 26 references it cites were found in a registry or an index.
Abstract
Background CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy) is commonly overlooked or misdiagnosed owing to its recent identification and its variable mode of presentation. The defective gene in CADASIL is Notch3, which encodes a large transmembrane receptor. To set up a diagnostic test and to delineate the Notch3 domains involved in CADASIL., we undertook mutations analysis in this gene in a group of CADASIL patients.Methods 50 unrelated patients with CADASIL and 100 healthy controls were screened for mutations along the entire Notch3 sequence, by means of single-strand conformation polymorphism, heteroduplex, and sequence analysis.Findings Strongly stereotyped mis-sense mutations, located within the epidermal-growth-factor-like (EGF-like) repeats, in the extracellular domain of Notch3, were detected in 45 patients. Clustering of mutations within the two exons encoding the first five EGF-like repeats was observed (32 patients). All these mutations lead to loss or gain of a cysteine residue and therefore to an unpaired number of cysteine residues within a given EGF domain. None of these mutations was found in the 100 controls.Interpretation Because of the strong clustering and highly stereotyped nature of the pathogenetic mutations detected in CADASIL patients, and easy and reliable diagnostic test for CADASIL is feasible. The findings suggest that aberrant dimerisation of Notch3, due to abnormal disulphide bridging with another Notch3 molecule or with another protein, may be involved in the pathogenesis of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.165”
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Self-citationArtavanis-Tsakonas, S., Matsuno, K., & Fortini, M. E. (1995) · Science · doi:10.1126/science.7716513 · Cited by 1,303
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., & Artavanis-Tsakonas, S. (1991) · Cell · doi:10.1016/0092-8674(91)90064-6 · Cited by 772
Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G. M., Chabriat, H., Mas, J.-L., Cabanis, E.-A., Baudrimont, M., Maciazek, J., et al. (1993) · Nature Genetics · doi:10.1038/ng0393-256 · Cited by 682
Self-citationClinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669
Self-citationRebay, I., Fehon, R. G., & Artavanis-Tsakonas, S. (1993) · Cell · doi:10.1016/0092-8674(93)90423-n · Cited by 409
Epidermal growth factor-like modules
Campbell, I. D., & Bork, P. (1993) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(05)80111-3 · Cited by 351
Ruchoux, M. M., Guerouaou, D., Vandenhaute, B., Pruvo, J.-P., Vermersch, P., & Leys, D. (1995) · Acta Neuropathologica · doi:10.1007/bf00571504 · Cited by 329
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study.
Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., & Bousser, M. G. (1993) · Stroke · doi:10.1161/01.str.24.1.122 · Cited by 321
Self-citation
Research works printed but not linked: 1
- Davous, 1991, Démence sous corticale familiale avec leucoencéphalopathie artériopathique: observation clinicopathologique., Rev Neurol (Paris), 5, 376
Cited by
Items 201–300 of 735
Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases
Salazar, J. L., & Yamamoto, S. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89512-3_8 · Cited by 51
Genetic architecture of common non-Alzheimer’s disease dementias
Guerreiro, R. J., Gibbons, E., Tábuas‐Pereira, M., Kun‐Rodrigues, C., Cordeiro, G., & Brás, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104946 · Cited by 51
Boucher, J. M., Harrington, A. N., Rostama, B., Lindner, V., & Liaw, L. (2013) · Circulation Research · doi:10.1161/circresaha.113.301272 · Cited by 51
“Notch3 was characterized as a major regulator of VSMC development(4) and is mutated in human cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy.(5) We now understand that signaling through Notch2 and Notch1 also activate pathways required during embryonic vascular development a…”
Background7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL
Liem, M. K., Lesnik Oberstein, S. A. J., Versluis, M. J., Maat-Schieman, M. L. C., Haan, J., Webb, A. G., Ferrari, M. D., van Buchem, M. A., & van der Grond, J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302545 · Cited by 50
notch3 is essential for oligodendrocyte development and vascular integrity in zebrafish
Zaucker, A., Mercurio, S., Sternheim, N., Talbot, W. S., & Marlow, F. L. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012005 · Cited by 50
“Many pathological mutations in CADASIL result in an odd number of cysteines in one of the EGF repeats of NOTCH3, which is thought to cause aggregation of the NOTCH3 extracellular domain (NECD) in individuals with CADASIL (Joutel et al., 1997; Opherk et al., 2009).”
BackgroundLens, X. M., Fernandez-Banet, J., Outeda, P., & Lucía, V. B. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.003 · Cited by 50
Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue
Mizuno, T., Muranishi, M., Torugun, T., Tango, H., Nagakane, Y., Kudeken, T., Kawase, Y., Kawabe, K., Oshima, F., Yaoi, T., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1391 · Cited by 49
“These mutations are thought to change the conformation of EGF-like repeats due to altered covalent bonding between cysteine residues (9).”
Hack, R. J., Cerfontaine, M. N., Gravesteijn, G., Tap, S., Hafkemeijer, A., van der Grond, J., Witjes-Ané, M.-N., Baas, F., Rutten, J. W., & Lesnik Oberstein, S. A. J. (2022) · Stroke · doi:10.1161/strokeaha.122.039325 · Cited by 42
How common are single gene mutations as a cause for lacunar stroke? A targeted gene panel study
Tan, R. Y. Y., Traylor, M., Mégy, K., Duarte, D., Deevi, S. V. V., Shamardina, O., Mapeta, R. P., Ouwehand, W. H., Gräf, S., Downes, K., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008544 · Cited by 49
“Often for cost reasons this involves sequencing a subset of exons, such as in CADASIL, where exons 3 and 4 are most frequently affected, and therefore preferentially screened.(6) As the spectrum of monogenic SVD expands, testing on a gene-by-gene basis is not cost- or time-effective.”
BackgroundBiochemical Characterization and Cellular Effects of CADASIL Mutants of NOTCH3
Meng, H., Zhang, X., Yu, G., Lee, S. J., Chen, Y. E., Prudovsky, I. A., & Wang, M. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044964 · Cited by 49
“cause the arterial pathology seen in CADASIL [12,13,14,15,16].”
BackgroundProlonged Cerebral Transit Time in CADASIL: A Transcranial Ultrasound Study
Liebetrau, M., Herzog, J., Kloss, C. U. A., Hamann, G. F., & Dichgans, M. (2002) · Stroke · doi:10.1161/hs0202.102949 · Cited by 49
Ahearn, E. P., Speer, M. C., Chen, Y. T., Steffens, D. C., Cassidy, F., Meter, S. A. V., Provenzale, J. M., Weisler, R. H., & Krishnan, K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10512 · Cited by 49
A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL
Mazzei, R., Conforti, F. L., Lanza, P. L., Sprovieri, T., Lupo, M. R., Gallo, O., Patitucci, A., Magariello, A., Caracciolo, M., Gabriele, A. L., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000133399.37716.84 · Cited by 48
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL
Peters, N., Freilinger, T. M., Opherk, C., Pfefferkorn, T., & Dichgans, M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0876-9 · Cited by 48
“For all CADASIL patients, the diagnosis had been established by detection of a Notch3 mutation or by skin biopsy with ultrastructural analysis [4, 5, 26–28].”
MethodMonogenic Vessel Diseases Related to Ischemic Stroke: A Clinical Approach
Ballabio, E., Bersano, A., Bresolin, N., & Candelise, L. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600520 · Cited by 48
“%) and suggested sequencing of these exons as the first step (Joutel et al, 1997).”
BackgroundNannucci, S., Rinnoci, V., Pracucci, G., MacKinnon, A. D., Pescini, F., Adib‐Samii, P., Bianchi, S., Dotti, M. T., Federico, A., Inzitari, D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190878 · Cited by 48
Mitochondrial dysfunction associated with a mutation in the Notch3 gene in a CADASIL family
de la Peña, P., Bornstein, B., del Hoyo, P., Fernández‐Moreno, M. Á., Martín, M. A., Campos, Y., Gómez-Escalonilla, C., Molina, J. A., Cabello, A., Arenas, J., et al. (2001) · Neurology · doi:10.1212/wnl.57.7.1235 · Cited by 48
Lundkvist, J., Zhu, S., Hansson, E. M., Schweinhardt, P., Miao, Q., Beatus, P., Dannaeus, K., Karlström, H., Johansson, C. B., Viitanen, M. H., et al. (2005) · genesis · doi:10.1002/gene.20091 · Cited by 47
“We wanted to make a CADASIL mouse mimicking one of the most common mutations in human CADASIL patients, R141C (Joutel et al., 1997).”
BackgroundInfluentialLiem, M. K., Oberstein, S. A. J. L., Vollebregt, M. J., Middelkoop, H. A. M., van der Grond, J., & den Enden, A. T. J. M. H.-V. (2008) · Journal of Neurology · doi:10.1007/s00415-009-0036-x · Cited by 47
CADASIL: Notch signaling defect or protein accumulation problem?
Spinner, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9511 · Cited by 47
“Through positional cloning, Notch3 was found to be the gene responsible for the disorder (1), and mutations have been demonstrated in more than 90% of CADASIL patients (1, 2).”
BackgroundGenetics of Vascular Cognitive Impairment: The Opportunity and the Challenges
Leblanc, G. G., Meschia, J. F., Stuss, D. T., & Hachinski, V. (2005) · Stroke · doi:10.1161/01.str.0000195177.61184.49 · Cited by 48
CADASIL with cord involvement associated with a novel and atypical NOTCH3 mutation
Bentley, P., Wang, T., Malik, O., Nicholas, R., Ban, M., Sawcer, S. J., & Sharma, P. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.223297 · Cited by 46
“The underlying molecular defect of CADASIL resides in Notch3—a transmembrane protein expressed in vascular smooth muscle cells—resulting in impaired cerebrovascular autoregulation, hypoperfusion and ischaemia.”
BackgroundDupé, C., Guey, S., Biard, L., Dieng, S., Lebenberg, J., Grosset, L., Alili, N., Hervé, D., Tournier‐Lasserve, E., Jouvent, É., et al. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221126280 · Cited by 46
“The minimal prevalence of the disease was initially estimated around 2–5 per 100,000 in Europe(20,21) with most mutations detected in symptomatic subjects clustering within a hotspot encompassing the EGFr domains from 1 to 6 of the NOTCH3 receptor.(3) Recently, the discovery of an unexpectedly large number of cysteine…”
BackgroundSelf-citationThe role of genetics in stroke
Francis, J., Raghunathan, S. K., & Khanna, P. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.060319 · Cited by 46
“The human NOTCH3 gene on chromosome 19p13.1–13.2 encodes the human Notch3 receptor, a 2321 amino acid type I transmembrane protein that forms part of the notch intercellular communication system. This system is thought to be involved in controlling cell fate during development and has important roles in arterial devel…”
BackgroundInfluentialGene expression in pharyngeal arch 1 during human embryonic development
Cai, J., Ash, D., Kotch, L. E., Jabs, E. W., Attié‐Bitach, T., Augé, J., Mattei, G., Etchevers, H., Vekemans, M. J. J., Korshunova, Y. O., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi083 · Cited by 46
“Some of these ‘enriched’ genes are known to be involved in human disorders affecting the craniofacial region such as GPC3 in Simpson-Golabi-Behmel syndrome type I (23,24), NOTCH3 in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (25) and TNFRSF10B in head and neck squamous c…”
BackgroundBOUSSER, M.-G. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.285 · Cited by 41
Self-citationSorsby fundus dystrophy:Insights from the past and looking to the future
Anand‐Apte, B., Chao, J. R., Singh, R., & Stöhr, H. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24317 · Cited by 45
Experimental studies of mitochondrial function in CADASIL vascular smooth muscle cells
Viitanen, M. H., Sundström, E., Baumann, M., Pöyhönen, M., Tikka, S., & Behbahani, H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.09.015 · Cited by 45
Pescini, F., Cesari, F., Giusti, B., Sarti, C., Zicari, E., Bianchi, S., Dotti, M. T., Federico, A., Balestrino, M., Enrico, A., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.563726 · Cited by 45
Valenti, R., Pescini, F., Antonini, S., Castellini, G., Poggesi, A., Bianchi, S., Inzitari, D., Pallanti, S., & Pantoni, L. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01512.x · Cited by 45
Genetics of Cerebrovascular Disorders
Meschia, J. F., Brott, T. G., & Brown, R. D. (2005) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62969-8 · Cited by 45
Migraine with aura and white matter abnormalities: Notch3 mutation
Ceroni, M., Poloni, T. E., Tonietti, S., Fabozzi, D., Uggetti, C., Frediani, F., Simonetti, F., Malaspina, A., Alimonti, D., Celano, M., et al. (2000) · Neurology · doi:10.1212/wnl.54.9.1869 · Cited by 45
Cardinal, R. N., & Bullmore, E. T. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511686917 · Cited by 44
Pescini, F., Bianchi, S., Salvadori, E., Poggesi, A., Dotti, M. T., Federico, A., Inzitari, D., & Pantoni, L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.10.017 · Cited by 44
Dupré, N., Gueniot, F., Domenga, V., Dubosclard, V., Nilles, C., Hill‐Eubanks, D. C., Morgenthaler-Roth, C., Nelson, M. T., Keime, C., Danglot, L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175789 · Cited by 43
Self-citationAnalysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
Orme, T., Hernandez, D., Ross, O. A., Kun-Rodrigues, C., Darwent, L., Shepherd, C. E., Parkkinen, L., Ansorge, O., Clark, L., Honig, L. S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0879-z · Cited by 41
“00003989 2 (113234) Found in several CADASIL, but also seen in 1 control Homozygous variant carrier had a mild phenotype [14, 33, 43, 68]”
Somatic mosaicism associated with a mild Alport syndrome phenotype: Figure 1
Plant, K. E., BOYE, E., GREEN, P. M., Vetrie, D. L. P., & Flinter, F. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.238 · Cited by 44
Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
Hack, R. J., Rutten, J. W., Person, T. N., Li, J., Khan, A., Griessenauer, C. J., Regeneron Genetics Center, Abedi, V., Lesnik Oberstein, S. A. J., & Zand, R. (2020) · Stroke · doi:10.1161/strokeaha.120.030343 · Cited by 37
Genetic susceptibility and ischaemic stroke
Elbaz, A., & Amarenco, P. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199902000-00009 · Cited by 42
Boston, G., Jobson, D., Mizuno, T., Ihara, M., & Kalaria, R. N. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100227 · Cited by 41
“Not surprisingly, majority of the most common mutations determined in this report were located within the EGFr 1 – 6 domain [22], where strong disease-associated variant clustering occurs and the phenotypes of mutation carriers are characterised by more aggressive disease [55].”
BackgroundLiem, M. K., van der Grond, J., Versluis, M. J., Haan, J., Webb, A. G., Ferrari, M. D., van Buchem, M. A., & Lesnik Oberstein, S. A. J. (2010) · Stroke · doi:10.1161/strokeaha.110.586883 · Cited by 40
Venkatesh, D., Park, K.-S., Harrington, A. N., Miceli‐Libby, L., Yoon, J. K., & Liaw, L. (2008) · Circulation Research · doi:10.1161/circresaha.108.177808 · Cited by 40
Schoemaker, D., & Arboleda‐Velásquez, J. F. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.03.015 · Cited by 40
Peripheral nerve and skeletal muscle involvement in CADASIL
Schröder, J. M., Zuchner, S. L., Dichgans, M., Nagy, Z., & Molnár, M. J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1082-9 · Cited by 40
“tensity [6], although cortical lesions may also occur [34]; (2) by the presence of pathognomic granular osmiophilic material (GOM) [3] in the arterial walls from skin, muscle [6, 13, 35, 36], sural nerve [43], ocular blood vessels [15] or other tissues [34, 35, 36]; and (3) by identification of the Notch3 gene mutatio…”
BackgroundHereditary Vascular Dementia Linked to Notch 3 Mutations: CADASIL in British Families
THOMAS, N. J., MORRIS, C. M., SCARAVILLI, F., JOHANSSON, J., ROSSOR, M., DE LANGE, R., ST CLAIR, D., NICOLL, J., BLANK, C., COULTHARD, A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06379.x · Cited by 34
CADASIL Syndrome: A Genetic Form of Vascular Dementia
Salloway, S., & Hong, J. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879801100205 · Cited by 47
Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes
Sierant, M. C., Jin, S. C., Bilgüvar, K., Morton, S. U., Dong, W., Jiang, W., Lu, Z., Li, B., López‐Giráldez, F., Tikhonova, I., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420343122 · Cited by 39
“These variants are analogous to mutations in NOTCH3 that cause CADASIL ( 59 ).”
CADASIL: Treatment and Management Options
Bersano, A., Bedini, G., Oskam, J. A., Mariotti, C., Taroni, F., Baratta, S., & Parati, E. A. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0468-z · Cited by 39
Finnilä, S., Tuisku, S., Herva, R., & Majamaa, K. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100268 · Cited by 39
“At least 25 missense mutations have been found, leading either to the gain or the loss of a cysteine residue in the extracellular, N-terminal domain of the molecule [5].”
BackgroundMutations of the Notch3 Gene in Non-Caucasian Patients with Suspected CADASIL Syndrome
Kotorii, S., Takahashi, K., Kamimura, K., Nishio, T., Arima, K., Yamada, H., Uyama, E., Uchino, M., Suenaga, A., Matsumoto, M., et al. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051256 · Cited by 37
Diagnostic strategies in CADASIL
Razvi, S., Davidson, R., Bone, I., & Muir, K. W. (2003) · Neurology · doi:10.1212/wnl.60.12.2019 · Cited by 39
Prevalence and clinical characteristics of stroke patients with p.R544C NOTCH3 mutation in Taiwan
Tang, S., Chen, Y.-R., Chi, N., Chen, C., Cheng, Y., Hsieh, F., Hsieh, Y., Yeh, H., Sung, P., Hu, C., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.690 · Cited by 38
Characteristic Features of in vivo Skin Microvascular Reactivity in CADASIL
Gobron, C., Vahedi, K., Vicaut, E., Stucker, O., Laemmel, E., Baudry, N., Bousser, M. G., & Chabriat, H. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600356 · Cited by 36
“…the most frequent inherited small-artery disease characterized by recurrent ischemic stroke and dementia, is caused by highly stereotyped mutations in the Notch3 receptor (Joutel et al, 1996, 1997) expressed at the surface of vascular smooth muscle cells (VSMC) (Joutel et al, 2000).”
BackgroundSelf-citationRole of Electron Microscopy in the Diagnosis of Cadasil Syndrome: A Study of 32 Patients
Morroni, M., Marzioni, D., Ragno, M., Bella, P. D., Cartechini, E., Pianese, L., Lorenzi, T., Castellucci, M., & Scarpelli, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065482 · Cited by 38
“The postnatal expression of the gene is mostly restricted to vascular smooth muscle cells (VSMCs) of middle and small arteries and pericytes [1,3].”
BackgroundA novel hereditary small vessel disease of the brain
Verreault, S., Joutel, A., Riant, F., Neves, G., Rui Silva, M., Maciazek, J., Tournier‐Lasserve, E., Bousser, M., & Chabriat, H. (2006) · Annals of Neurology · doi:10.1002/ana.20775 · Cited by 39
“Each of the 23 exons encoding for epidermal growth factor (EGF) motifs were sequenced as previously described.(11) NOTCH3 haplotype analysis was conducted as previously described.”
MethodSelf-citationVasculopathic Changes of CADASIL Can Be Focal in Skin Biopsies
Schultz, A. B. (1999) · Ultrastructural Pathology · doi:10.1080/019131299281572 · Cited by 38
NOTCH3 Variants and Genotype-Phenotype Features in Chinese CADASIL Patients
Hu, Y., Sun, Q., Zhou, Y., Yi, F., Tang, H., Yao, L., Tian, Y., Xie, N., Luo, M., Wang, Z., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.705284 · Cited by 37
Tikka, S., Ng, Y. P., Maio, G. D., Mykkänen, K., Siitonen, M., Lepikhova, T., Pöyhönen, M., Viitanen, M. H., Virtanen, I., Kalimo, H., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.123 · Cited by 37
Early visual function impairment in CADASIL
Parisi, V., Pierelli, F., Fattapposta, F., Bianco, F., Parisi, L., Restuccia, R., Malandrini, A., Ferrari, M., & Carrera, P. (2003) · Neurology · doi:10.1212/01.wnl.0000070411.13217.7e · Cited by 37
CADASIL: Hereditary Arteriopathy Leading to Multiple Brain Infarcts and Dementia
Viitanen, M. H., & Kalimo, H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06377.x · Cited by 37
Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells
Hanemaaijer, E. S., Panahi, M., Swaddiwudhipong, N., Tikka, S., Winblad, B. G., Viitanen, M. H., Piras, A., & Behbahani, H. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.10.001 · Cited by 36
“These mutations may have various functional consequences on the NOTCH3 receptor, including abnormal folding or dimerization, impairment of interaction with its ligands, and aberrant interaction with other proteins (Joutel et al., 1997).”
BackgroundLiu, X.-Y., Gonzalez-Toledo, M. E., Fagan, A., Duan, W.-M., Liu, Y., Zhang, S., Li, B., Piao, C.-S., Nelson, L., & Zhao, L.-R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.006 · Cited by 36
Bardot, B., Mok, L., Thayer, T. C., Ahimou, F., & Wesley, C. S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.030 · Cited by 37
“As, both N andN mutations ofDrosophila Notch receptor lead to an odd number of cysteines in one of the EGF-like repeats, they can be considered as typical CADASIL-like mutations [24].”
BackgroundInfluentialCADASIL syndrome in a large Turkish kindred caused by the R90C mutation in the Notch3 receptor
Utku, U., Çelik, Y., Uyguner, Z. O., Yüksel‐Apak, M., & Wollnik, B. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00344.x · Cited by 36
“Approximately 75% of all known mutations are located in exons 3 and 4 of the gene (Joutel et al., 1997).”
BackgroundInfluentialCADASIL: Extended polymorphisms and mutational analysis of the NOTCH3 gene
Ungaro, C., Mazzei, R., Conforti, F. L., Sprovieri, T., Servillo, P., Liguori, M., Citrigno, L., Gabriele, A. L., Magariello, A., Patitucci, A., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21935 · Cited by 36
“Moreover, the peculiar distribution of NOTCH3 gene mutations emerging TABLE I. Mutations Identified in the NOTCH3 Gene Members/families Exon AA change References 1/1 Exon 2 R54C Escary et al. (2000) Hum Mutat 16:518 9/3 Exon 3 R90C Joutel et al. (1997) Lancet 350:1511 2/3 Exon 3 R110C Joutel et al. (1997) Lancet 350:1…”
BackgroundInfluentialGravesteijn, G., Munting, L. P., Overzier, M., Mulder, A. A., Hegeman, I. M., Derieppe, M., Koster, A. J., van Duinen, S. G., Meijer, O. C., Aartsma-Rus, A. M., et al. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00742-7 · Cited by 35
Soong, B., Liao, Y., Tu, P., Tsai, P., Lee, I., Chung, C., & Lee, Y. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.03.002 · Cited by 35
“There are six cysteine residues within each EGF-like repeat and almost all mutations identified in CADASIL to date result in either a gain or loss of one cysteine residue within a given EGF-like repeat domain of the NOTCH3 protein.(5) As the NOTCH3 mutations leave one cysteine residue unpaired, which provides one free…”
BackgroundNeurovascular dysfunction in dementia – human cellular models and molecular mechanisms
Parkes, I., Chintawar, S., & Cader, M. Z. (2018) · Clinical Science · doi:10.1042/cs20160720 · Cited by 35
Effects of Cerebral Blood Flow and White Matter Integrity on Cognition in CADASIL Patients
Yin, X., Zhou, Y., Yan, S., & Lou, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00741 · Cited by 35
Min, J.-Y., Park, S., Kang, E.-J., Hwang, S.-Y., & Han, S. (2021) · Neurogenetics · doi:10.1007/s10048-021-00674-1 · Cited by 34
“The characteristic cysteinealtering missense pathogenic variants in the NOTCH3 gene have been described in CADASIL patients, which are highly clustered between exons 1 through 6 [3, 4].”
BackgroundAbou‐Al‐Shaar, H., Qadi, N., Al‐Hamed, M. H., Meyer, B. F., & Bohlega, S. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.061 · Cited by 34
Brandl, C., Schulz, H. L., Issa, P. C., Birtel, J., Bergholz, R., Lange, C., Dahlke, C., Zobor, D., Weber, B. H. F., & Stöhr, H. (2017) · Genes · doi:10.3390/genes8070170 · Cited by 34
“Disruption of the disulfide bond pattern of EGF-like domains plays a major role in the pathogenesis of several inherited diseases [21,22].”
BackgroundMorgan, L., & Humphries, S. E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162324.85290.ac · Cited by 34
CYSTEINE-SPARING NOTCH3 MUTATIONS: CADASIL OR CADASIL VARIANTS?
Quattrone, A., & Mazzei, R. (2009) · Neurology · doi:10.1212/01.wnl.0000349699.12456.06 · Cited by 33
Brass, S. D., Smith, E. E., Arboleda‐Velásquez, J. F., Copen, W. A., & Frosch, M. P. (2009) · New England Journal of Medicine · doi:10.1056/nejmcpc0810839 · Cited by 33
Hagel, C., Groden, C., Niemeyer, R., Stavrou, D., & Colmant, H. J. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0887-2 · Cited by 33
“According to the literature, the geographically most widespread form of hereditary SAE (HSAE) is a vasculopathy designated with the acronym CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukencephalopathy) extensively investigated by Tournier-Lasserve et al. [ 20 ,42].”
BackgroundAngeli, S., Carrera, P., Sette, M. D., Assini, A., Grandis, M., Biancolini, D., Ferrari, M., & Gandolfo, C. (2001) · European Neurology · doi:10.1159/000050804 · Cited by 33
“Recently, the genetic defect involved and the mechanisms underlying the disease have been described [ ,”
BackgroundWang, T., Sharma, S. D., Fox, N., Rossor, M., Mj, B., & Sharma, P. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.652 · Cited by 33
“Mutations clustering in exons 3 and 4 account for about 65% of all patients with CADASIL.”
BackgroundAn Animal Model for the Molecular Genetics of CADASIL
Fryxell, K. J., Soderlund, M., & Jordan, T. V. (2001) · Stroke · doi:10.1161/01.str.32.1.6 · Cited by 32
Zhou, W., Xia, S., Wang, C., Yang, Q., Verkhratsky, A., & Niu, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07893-6 · Cited by 31
“…pattern of NOTCH3 and the key pathological characteristics of CADASIL, including the accumulation of the NOTCH3 extracellular domain in cerebral blood vessels, the deposition of granular osmiophilic material, a gradual decline in white matter integrity, and diminished brain perfusion [372, 373].”
Association of a Notch 3 gene polymorphism with migraine susceptibility
Menon, S., Cox, H. C., Kuwahata, M., Quinlan, S., MacMillan, J., Haupt, L. M., Lea, R. A., & Griffiths, L. R. (2010) · Cephalalgia · doi:10.1177/0333102410381143 · Cited by 31
“Exons 3 and 4 of the Notch 3 gene are hot spots for most of the CADASIL causative mutations (6).”
BackgroundParkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities
Ramirez, J., Dilliott, A. A., Binns, M. A., Breen, D. P., Evans, E. C., Beaton, D., McLaughlin, P. M., Kwan, D. T., Holmes, M. F., Ozzoude, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28171 · Cited by 31
“Traditionally, pathogenic variants for CADASIL were considered those that occurred in an EGF-like repeat (most commonly EGF-like repeats 1–6) and contributed to the loss or gain of a cysteine residue.(22) These variants disrupt disulphide bridging, which leads to protein misfolding and ultimately NOTCH3 protein aggreg…”
BackgroundSelf-citationCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Chabriat, H., & Bousser, M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01261-4 · Cited by 30
Self-citationGenetic Variants of the NOTCH3 Gene in Migraine—A Mutation Analysis and Association Study
Schwaag, S., Evers, S., Schirmacher, A., Stögbauer, F., Ringelstein, E. B., & Kuhlenbäumer, G. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2005.01007.x · Cited by 30
Coexistence of CADASIL and Alzheimer's disease
Thijs, V., Robberecht, W., Vos, R. D., & Sciot, R. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.790 · Cited by 29
“According to the criteria of Braak and Braak, the Alzheimer related changes correspond to stage V.”
Identification of a Known Mutation in Notch 3 in Familiar CADASIL in China
Tan, Z.-X., Li, F.-F., Qu, Y.-Y., Liu, J., Liu, G.-R., Zhou, J., Zhu, Y., & Liu, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036590 · Cited by 29
“The result of multiple-sequence alignments showed that Arg133, mutation of which was previously described by Joutel [15] and Mykkanen [16], was a conserved residue, indicating its importance for normal NOTCH3 function.”
BackgroundEffects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL
Peters, N., Freilinger, T. M., Opherk, C., Pfefferkorn, T., & Dichgans, M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.04.015 · Cited by 29
“For all CADASIL patients, the diagnosis had been established by detection of aNotch3mutation or by skin biopsy with ultrastructural analysis [20–24].”
MethodCumurciuc, R., Henry, P., Gobron, C., Vicaut, É., Bousser, M., Chabriat, H., & Vahedi, K. (2006) · Stroke · doi:10.1161/01.str.0000209242.68844.20 · Cited by 29
Self-citationInterferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis
Constantin, A., Navaux, F., Lauwers‐Cancès, V., Abbal, M., van Meerwijk, J. P. M., Mazières, B., Cambon‐Thomsen, A., & Cantagrel, A. G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07143-4 · Cited by 29
Abramycheva, N., Stepanova, M., Kalashnikova, L., Zakharova, M., Maximova, M., Tanashyan, M., Lagoda, O., Fedotova, E., Klyushnikov, S., Konovalov, R., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.01.018 · Cited by 28
“1 6565686 TAC → TGC Y189C 4 EGFR 4 [35] 1 6565672 TGT → GGT C194G* 4 EGFR 4 – 2 6565633 CGT → TGT R207C 4 EGFR 5 [40] 1 6565587 TGT → TAT C222Y 4 EGFR 5 [33] 1 6565406 GTG → ATG V252M* 5 EGFR 6 – 1 6565387 TAT → TGT Y258С 5 EGFR 6 [14] 2 6565109 GTG → ATG V322M 6 EGFR 8 NCBI Single Nucleotide Polymorphism Database (db…”
BackgroundInfluentialPolychronidou, E., Vlachakis, D. P., Vlamos, P., Baumann, M., & Κοσσίδα, Σ. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-08927-0_6 · Cited by 28
“It consists of 33 exons spanning 7 kilobases and encodes a transmembrane receptor of 2321 amino acids involved in cellular signaling and fate during embryonic development (Joutel et al. 1997).”
BackgroundHutchinson, S., Aplin, R. T., Webb, H., Kettle, S., Timmermans, J., Boers, G. H. J., & Handford, P. A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.038 · Cited by 28
Oliveri, R. L., Muglia, M., Stefano, N. D., Mazzei, R., Labate, A., Conforti, F. L., Patitucci, A., Gabriele, A. L., Tagarelli, G., Magariello, A., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1418 · Cited by 28
“In the past few years, there has been increasing evidence that the clinical picture of CADASIL is highly heterogeneous, ranging from severe dementia to migraine with aura, associated with white matter abnormalities.(4,8,10) Moreover, it has recently emerged that sporadic cases also exist, as mutation in the Notch3 gen…”
BackgroundChabriat, H., & Bousser, M. (1997) · Primer on Cerebrovascular Diseases · doi:10.1016/b978-012743170-3/50113-8 · Cited by 28
Self-citationCesari, F., Nencini, P., Nesi, M., Caporale, R., Giusti, B., Abbate, R., Gori, A. M., & Inzitari, D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.178 · Cited by 27
Animal models of monogenic migraine
Chen, S., Tolner, E. A., & Eikermann‐Haerter, K. (2016) · Cephalalgia · doi:10.1177/0333102416645933 · Cited by 27
Cerebrovascular disorders associated with genetic lesions
Karschnia, P., Nishimura, S., & Louvi, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2934-5 · Cited by 27
Testi, S., Malerba, G., Ferrarini, M., Ragno, M., Pradotto, L., Mauro, A., & Fabrizi, G. M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.025 · Cited by 27
“3%) than in other European populations (50–70%) [16–18,20], and it was followed by exons 19 (24%) and 7 (21%).”
Notch3 gene polymorphism and ischaemic cerebrovascular disease
Ito, D., Tanahashi, N., Murata, M., Sato, H., Saito, I., Watanabe, K., & Fukuuchi, Y. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.3.382 · Cited by 26
Binswanger Disease: The History of a Silent Epidemic
Román, G. C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06345.x · Cited by 26
Metadata
- Authors
- Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., Bach, J.-F., & Tournier-Lasserve, E.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Hôpital Lariboisière (FR)
- bioMérieux (France) (FR)
- Genethon (France) (FR)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 350
- Issue
- 9090
- Pages
- 1511-1515
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153287135
- Cited by
- 682
- References
- 26
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 22 · 2023: 21 · 2022: 27 · 2021: 16 · 2020: 30 · 2019: 20 · 2018: 28 · 2017: 16 · 2016: 12 · 2015: 18 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CADASIL, Notch3, NOTCH3 mutations, EGF-like repeats, mutation clustering, diagnostic testing, cerebrovascular disease, leukoencephalopathy
- MeSH terms
- Receptor, Notch3, Cerebral Arterial Diseases, Cerebral Infarction, DNA Mutational Analysis, Epidermal Growth Factor, Genetic Testing, Genotype, Humans, Leukoencephalopathy, Progressive Multifocal, Mutation, Proto-Oncogene Proteins, Receptors, Cell Surface, Case-Control Studies, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.